The U.S. FDA granted breakthrough device designation to Mursla Bio Ltd.'s Evoliver. The biopsy blood test uses extracellular vesicles to survey hepatocellular carcinoma in high-risk cirrhotic patients ...

Researchers have developed a new blood test that can identify cancer in the body as part of a National Health Service (NHS) ...

Doctors might be able to predict a newborn's long-term health outlook, by analyzing their umbilical cord blood, a new study ...